Nabumetone
Product Images NDC 70934-347

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 70934-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

A data table comparing pharmacokinetic parameters for Nabumetone in young adults and elderly subjects. Parameters include Tmax (hours), half-life (t1/2 in hours), clearance (CLss/F in mL/min), and volume of distribution (Vdss/F in liters), with mean values and standard deviations reported for different doses and age groups.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

Table showing the number of osteoarthritis (OA) and rheumatoid arthritis (RA) patients and the mean and mode duration of Nabumetone treatment in years at doses of 500 mg, 1,000 mg, 1,500 mg, and 2,000 mg.*

FDA Label Image

Metabolites (5276f530 14bcmetabolites)

A data table listing various metabolites of nabumetone with their respective percentage of the dose detected, including unchanged nabumetone and several conjugated forms such as 6-methoxy-2-naphthylacetic acid (6MNA), 6-hydroxy-2-naphthylacetic acid (6HNA), and others, with total percentage dose noted as 73%.*

FDA Label Image

6mna Plasma Concentrations (6mna Plasma Concentrations)

A line graph depicting Nabumetone active metabolite (6MNA) plasma concentrations over time at steady state following once-daily dosing of Nabumetone at 1000 mg (n=31) and 2000 mg (n=12). The x-axis represents time in hours (0 to 70), and the y-axis shows concentration in mcg/mL (0 to 120). The graph includes curves with standard deviation ranges for both dosages, with annotations marking 1000 mg and 2000 mg dosing times.*

FDA Label Image

6mna-structure (6mna Structure)

Chemical structure diagram of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone. The diagram shows a bicyclic naphthalene ring with methoxy and carboxylic acid substituents.*

FDA Label Image

Label (70934 347 30 Rev A 04 19)

Nabumetone Tablets, USP 750mg packaging label showing 30 tablets. The label states 'Rx Only' with dosage storage instructions and cautions to keep out of reach of children. Labeler is Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The NDC is 70934-347-30 with lot, expiration, and manufacturing details listed.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Nabumetone showing its molecular formula C15H16O2 and molecular weight 228.3. The structure includes aromatic rings, a methoxy group, and a ketone functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.